---
title: "Gossamer Bio sets initial warrant exercise price at $0.34 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291419760.md"
description: "Gossamer Bio has set the initial exercise price for its Purchase Warrants at $0.34 per share. The reference price used in the warrant pricing formula was determined to be $0.17, calculated over a seven-trading-day period starting June 22, 2026."
datetime: "2026-07-01T13:01:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291419760.md)
  - [en](https://longbridge.com/en/news/291419760.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291419760.md)
---

# Gossamer Bio sets initial warrant exercise price at $0.34 per share

-   Gossamer Bio set the initial exercise price for its Purchase Warrants at $0.34 per share. \* The Reference Price used in the warrant pricing formula was $0.17, calculated over seven trading days starting June 22, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gossamer Bio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607010900BIZWIRE\_USPR\_\_\_\_\_20260701\_BW862371) on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md)

## Related News & Research

- [Gossamer Bio shareholders approved convertible note exchange proposals at special meeting](https://longbridge.com/en/news/293920719.md)
- [Gossamer Bio Restructures Debt, Secures Full Control of Lead Drug Candidate](https://longbridge.com/en/news/293964802.md)
- [Boost Run sets USD 0.01 per warrant redemption, Aug. 20 exercise deadline](https://longbridge.com/en/news/293920690.md)
- [Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal](https://longbridge.com/en/news/294409414.md)
- [Columbus Circle Capital III units begin separate trading of shares, warrants July 31](https://longbridge.com/en/news/294261716.md)